{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:05:17Z","timestamp":1783649117034,"version":"3.55.0"},"reference-count":20,"publisher":"CSIRO Publishing","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,26]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives and importance of the study<\/jats:title>\n                    <jats:p>Chronic hepatitis B and C are leading causes of liver cancer in Australia, and understanding prevalence, diagnosis and care uptake is a public health priority in the context of a strategic commitment to elimination. This study aims to estimate the degree of movement between jurisdictions among people with hepatitis B and hepatitis C in Australia, to understand the impact on national notifications data, and the implications for modelling of prevalence and diagnosis, and consequently uptake measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study type<\/jats:title>\n                    <jats:p>This is a retrospective cohort study using linked health service provision data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Individuals who received Medicare services restricted to those diagnosed with hepatitis B or hepatitis C (nucleic acid testing or treatment) via Medicare during 2011\u20132023 were analysed. The proportion who changed jurisdictions and the proportion who had a service in multiple jurisdictions were generated, with sub-analysis by jurisdiction and among priority populations (those born overseas and Aboriginal and\/or Torres Strait Islander peoples).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the cohort (n\u00a0=\u00a0137,041 hepatitis B; n\u00a0=\u00a0252,144 hepatitis C), 9.8% of those with hepatitis B and 15.1% of those with hepatitis C resided in more than one jurisdiction, ranging from 6.7 to 33.3% by jurisdiction for hepatitis B, and 11.8\u201342.8% for hepatitis C. This compares to 10.3% (range 8.0\u201328.9%) among the total Australian population. Movement was higher among Aboriginal and Torres Strait Islander peoples for hepatitis B, with a different pattern by jurisdiction than the total cohort. The proportion who had a hepatitis B or hepatitis C service in multiple jurisdictions was 3.2 and 4.6%, respectively, with similar trends by state and territory.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Movement among people with hepatitis B and C was highly variable according to jurisdiction. This movement should be accounted for in the use of notifications data according to geographic area, and in assessing national progress towards viral hepatitis elimination goals. Linkage of notification data across jurisdictions and with other data sources to improve utility should be considered a priority.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1071\/pu25051","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T04:52:22Z","timestamp":1764132742000},"source":"Crossref","is-referenced-by-count":1,"title":["Jurisdictional movement among people with hepatitis B and C in Australia: implications for national data"],"prefix":"10.1071","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7654-4536","authenticated-orcid":true,"given":"Jennifer H.","family":"MacLachlan","sequence":"first","affiliation":[{"name":"AWHO Collaborating Centre for Viral Hepatitis, The Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia."},{"name":"BDepartment of Infectious Diseases, University of Melbourne, Parkville, Vic, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Romero","sequence":"additional","affiliation":[{"name":"AWHO Collaborating Centre for Viral Hepatitis, The Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia."},{"name":"BDepartment of Infectious Diseases, University of Melbourne, Parkville, Vic, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2709-193X","authenticated-orcid":true,"given":"Stephen B.","family":"Lambert","sequence":"additional","affiliation":[{"name":"CCommunicable Diseases Branch, Queensland Health, Brisbane, Qld, Australia."},{"name":"DNational Centre for Immunisation Research and Surveillance, Sydney Children\u2019s Hospitals Network, Westmead, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Dore","sequence":"additional","affiliation":[{"name":"EKirby Institute, UNSW Sydney, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Gray","sequence":"additional","affiliation":[{"name":"EKirby Institute, UNSW Sydney, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisoo A.","family":"Kwon","sequence":"additional","affiliation":[{"name":"EKirby Institute, UNSW Sydney, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin C.","family":"Cowie","sequence":"additional","affiliation":[{"name":"AWHO Collaborating Centre for Viral Hepatitis, The Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia."},{"name":"BDepartment of Infectious Diseases, University of Melbourne, Parkville, Vic, Australia."},{"name":"FVictorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Vic, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"67","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"2026012817511871000_R1"},{"key":"2026012817511871000_R2"},{"key":"2026012817511871000_R3"},{"key":"2026012817511871000_R4"},{"issue":"9","key":"2026012817511871000_R5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257369","article-title":"Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications.","volume":"16","author":"Kwon","year":"2021","journal-title":"PLoS One"},{"key":"2026012817511871000_R6"},{"key":"2026012817511871000_R7"},{"key":"2026012817511871000_R8"},{"key":"2026012817511871000_R9","doi-asserted-by":"publisher","DOI":"10.33321\/cdi.2024.48.44","article-title":"Australian vaccine preventable disease epidemiological review series: Hepatitis B, 2000\u20132019.","volume":"48","author":"Sonneveld","year":"2024","journal-title":"Commun Dis Intell (2018)"},{"issue":"2","key":"2026012817511871000_R10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/1753-6405.12481","article-title":"Establishing a process for conducting cross-jurisdictional record linkage in Australia.","volume":"40","author":"Moore","year":"2016","journal-title":"Aust N Z J Public Health"},{"key":"2026012817511871000_R11"},{"key":"2026012817511871000_R12"},{"key":"2026012817511871000_R13"},{"issue":"1","key":"2026012817511871000_R14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/1753-6405.12934","article-title":"Epidemiology of chronic hepatitis B and C in Victoria, Australia: insights and impacts from enhanced surveillance.","volume":"44","author":"MacLachlan","year":"2020","journal-title":"Aust N Z J Public Health"},{"key":"2026012817511871000_R15"},{"key":"2026012817511871000_R16"},{"key":"2026012817511871000_R17"},{"issue":"3","key":"2026012817511871000_R18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2196\/publichealth.9800","article-title":"Cross-Jurisdictional Data Exchange Impact on the Estimation of the HIV Population Living in the District of Columbia: Evaluation Study.","volume":"4","author":"Hamp","year":"2018","journal-title":"JMIR Public Health Surveill"},{"issue":"6","key":"2026012817511871000_R19","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/s0277-9536(02)00487-2","article-title":"Short report: migration among persons living with HIV.","volume":"57","author":"Berk","year":"2003","journal-title":"Soc Sci Med"},{"key":"2026012817511871000_R20","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2024.101185","article-title":"Trends in viral hepatitis liver-related morbidity and mortality in New South Wales, Australia.","volume":"51","author":"Tillakeratne","year":"2024","journal-title":"Lancet Reg Health West Pac"}],"container-title":["Public Health Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/pu\/article-pdf\/doi\/10.1071\/PU25051\/1841174\/pu25051.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/pu\/article-pdf\/doi\/10.1071\/PU25051\/1841174\/pu25051.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T22:51:22Z","timestamp":1769640682000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/pu\/article\/36\/1\/PU25051\/266040\/Jurisdictional-movement-among-people-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3,26]]}},"URL":"https:\/\/doi.org\/10.1071\/pu25051","relation":{},"ISSN":["2204-2091"],"issn-type":[{"value":"2204-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"article-number":"PU25051"}}